Veli Kemal Topkara MD
Adult Congenital Heart Disease, Heart Failure & Transplantation
Physician
Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-263-1690
Fax+1 608-265-1918
Dr. Topkara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Advanced Heart Failure and Transplant Cardiology, 2013 - 2014
Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 2009 - 2013
Baylor College of MedicineResidency, Internal Medicine, 2006 - 2009
Sidney Kimmel Medical College at Thomas Jefferson UniversityInternship, Transitional Year, 2005 - 2006
Hacettepe University FOMClass of 2003
Certifications & Licensure
WI State Medical License 2024 - 2027
NY State Medical License 2013 - 2026
MO State Medical License Active through 2013
PA State Medical License 2005 - 2006
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Recurrent Cardiac Sarcoidosis After Heart Transplantation.Molly A Cole, Nandakumar Menon, Elise Strycharske, David Pham, Jefree J Schulte
JACC. Case Reports. 2025-10-07 - Sarcopenia Assessment Using Fully Automated Deep Learning Predicts Cardiac Allograft Survival in Heart Transplant Recipients.Frederick M Lang, Jianfei Liu, Kevin J Clerkin, Elissa A Driggin, Andrew J Einstein
Circulation. Heart Failure. 2025-10-01 - Exploring Mechanisms of Pulmonary Artery Banding in a Rat Model of Dilated Cardiomyopathy.Yi Ye, Veli K Topkara
JACC. Basic to Translational Science. 2025-08-01
Journal Articles
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicLauren Sinnenberg, Nosheen Reza, Michelle M Kittleson, Veli K Topkara, Maryjane A Farr, JAMA Cardiology
- VA‐ECMO for Cardiogenic Shock in the Contemporary Era of Heart Transplantation: Which Patients Should Be Urgently Transplanted?Yoshifumi Naka, Maryjane A Farr, Koji Takeda, Paolo Colombo, Hiroo Takayama, Arthur R Garan, Veli K Topkara, Clinical Transplantation
Authored Content
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
- Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
- Prognostic Impact of Pulmonary Artery Pulsatility Index (PAPi) in Patients with Advanced Heart Failure: Insights from the ESCAPE TrialMarch 2018
- Join now to see all
Press Mentions
LV Unloading and Myocardial Recovery : An Exciting Future in the Continuum of Remission to RecoveryMarch 30th, 2023
Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist DevicesJune 2nd, 2016
International Genome-Wide Association Study Consortium Identifies Novel Loci Associated with Blood Pressure in Children and AdolescentsMarch 11th, 2016- Join now to see all
Grant Support
- Role of RNA helicase Ddx5 in pathological cardiac remodelingUNIVERSITY OF WISCONSIN-MADISON2024–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
